Tag :

Medical Research Press Releases

Primate Research Organization Alpha Genesis Recognized in 2018 Grant Thornton SC100

Primate Research Organization Alpha Genesis Recognized in 2018 Grant Thornton SC100

​​​​​​Alpha Genesis has been named to the 2018 Grant Thornton South Carolina 100™ (SC100), which ranks the state’s largest private companies by revenue. The Yemassee-based Company provides primate products and research services world-wide and is an industry leader in the biomedical…

Primate CRO Alpha Genesis Continues Expansion Efforts With $3M Commitment

Primate CRO Alpha Genesis Continues Expansion Efforts With $3M Commitment

Primate contract research organization Alpha Genesis today announced the second phase of its multi-year expansion effort, committing an additional $3M over the next two years towards new construction and hiring to further enhance the Company's product and service offerings. This announcement…

iPatientAxis Applies Near-Time Medical Record Retrieval to Convert Trial Intenders to Enrollees

​A recent study looking at digital patient recruitment for clinical trials found that social media in particular offers significant upside when it comes to usability for trial education and ultimately, enrollment. The study, “Content That Clicks: Effective Social Marketing for…

FEBC: Who Will Be Wearing Pink for This Year's Breast Cancer Awareness Month?

October is National Breast Cancer Awareness Month. The chosen color of bright pink is seen more places, and people proudly wear the pink breast cancer ribbon to show their support of finding a cure. As of January of this year,…

International Symposium Convenes to Address Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders

With over 275 scientists, clinicians and patient organizations from around the world, The 2018 International Symposium on the Ehlers-Danlos Syndromes is bringing together the brightest minds in Ehlers-Danlos (EDS) research and clinical management to tackle some of the most pressing questions…

Genentech and Roche Welcomes Dr. Owen Garrick to the Steering Committee on Inclusive Research

Dr. Owen Garrick, CEO of Bridge Clinical Research, was invited to join Genentech and Roche’s Steering Committee on Inclusive Research.  “Genentech and Roche are committed to discovering and delivering medicines to treat patients with serious and life-threatening conditions. To continue…

MedAware Systems Curates its 30,000th Medical Research Study

MedAware Systems, Inc. announced today that it curated its 30,000th medical research study for the Company's Science of Health Informatics (SOHInfo™) database. This milestone far eclipses all previous efforts at extracting and normalizing data from the vast and disorganized body…

James Bourdage to Retire as BASi VP of Bioanalytical Operations; Michael Baim Named as Successor

Bioanalytical Systems Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that James Bourdage, Ph.D., vice president of Bioanalytical Operations, will retire as of May 4, 2018. Michael Baim, Ph.D., will assume the role of vice president of Bioanalytical Operations effective May 7, 2018.…

2,000 Clinical Trial Sites Now Manage eRegulatory for 600 Studies in Florence eBinders

Leading up to the Association of Clinical Research Professionals Annual Meeting in Washington D.C., Florence announced over 2,000 clinical trial teams are now actively managing the eRegulatory and eSource for 600+ Pharmaceutical and Medical Device studies in its eBinders solution. Founded in…

Texila American University in Academic Partnership With UCN Offers PhD in Medicine (Research Based)

Texila American University in Academic Partnership With UCN Offers PhD in Medicine (Research Based)

Texila American University in academic partnership with the University of Central Nicaragua (UCN) offers a Ph.D. in Medicine (Research Based).  Doctoral studies are carried out by preclinical students, medical professionals combining clinical training with the Ph.D., and clinically qualified doctors undertaking…

Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018

Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018

Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced today that it will report financial results for the first quarter of fiscal 2018 ended December 31, 2017, prior to the market opening on Tuesday, February 13, 2018. If there…

BASi Continues Profitability Improvement to Close Out Fiscal 2017

BASi Continues Profitability Improvement to Close Out Fiscal 2017

Bioanalytical Systems, Inc. (NASDAQ:BASI) (" BASi" or the "Company") today announced financial results for the three and twelve months ended September 30, 2017. Fourth Quarter Results For the three months ended September 30, 2017, revenue amounted to $5,873,000, a 14%…

Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017

Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017

Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that it will report financial results for the fourth quarter and twelve months ended September 30, 2017, prior to the market opening on Tuesday, December 19, 2017. If there are…

BASi Announces Enhanced Bioequivalence Capabilities

BASi Announces Enhanced Bioequivalence Capabilities

Bioanalytical Systems Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced a multi-tiered strategy aimed at enhancing the company’s in vitro and in vivo bioequivalence capabilities. Over the next several months, BASi will hire additional Principal Investigators and Research Analysts to support…

Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana

Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana

Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced the company has retained architects and consultants to design and complete a multi-phased plan for the expansion of its GLP toxicology facility in Mt. Vernon, Indiana, near Evansville. Steady growth and…

Advancing Healthcare and Clinical Research With Blockchain: Florence and Verady Form Partnership

Florence, the company advancing clinical research through software, and Verady, the Blockchain asset assurance company, today announced a partnership to develop applications harnessing Blockchain for advancing healthcare and clinical research. The announcement takes place at the Distributed:Health conference in Nashville, Tennessee, the leading conference exploring healthcare innovation through Blockchain. Florence…

Bioanalytical Systems to Release Third Quarter Fiscal 2017 Results on Monday, August 14, 2017

Bioanalytical Systems to Release Third Quarter Fiscal 2017 Results on Monday, August 14, 2017

Bioanalytical Systems, Inc. (NASDAQ:BASI) ("BASi" or the “Company") announced today that it will report financial results for the third quarter and nine months ended June 30, 2017, prior to the market opening on Monday, Aug. 14, 2017. If there are any…

BASi Completes Refinancing of Senior Secured Credit Facilities

BASi Completes Refinancing of Senior Secured Credit Facilities

​​​​​​​​​​​​​​​​​​​​Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that it has successfully completed the refinancing of its existing senior secured credit facility with a new senior secured credit facility, consisting of a $4.5 million term loan and a…

Vanillylacetona Primera Ayuda En PaÍses En Desarrollo

VANILLYLACETONE AS FIRST AID IN DEVELOPING COUNTRIESDoctor Anderson DossettiMiami, Florida  03/11/2016 (Rev. 03/16/2016)RESUMENVANILLYLACETONA PRIMERA AYUDA EN PAÍSES EN DESARROLLOLa vanillylacetona 4-(HO)C6H3-3-(OCH3)CH2CH2COCH3  soluble 1/50% de alcohol es hallada principalmente en algunas plantas de la familia de las zinguiberáceas.  La vanillylacetona  juega…

BASi Announces Validated 'SEND' Capabilities and Compliance With FDA's Standard for Exchange of Nonclinical Data

BASi Announces Validated 'SEND' Capabilities and Compliance With FDA's Standard for Exchange of Nonclinical Data

 Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced its “SEND” compliance with a fully integrated software solution for streamlining data management and reporting. In partnership with PDS Life Sciences (PDS), BASi has validated TranSEND™, a submission solution that…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login